• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores.利用深度学习衍生的胸部 X 光评分评估风湿性疾病与普通人群 COVID-19 肺部损伤的严重程度。
Arthritis Care Res (Hoboken). 2023 Mar;75(3):657-666. doi: 10.1002/acr.24883. Epub 2022 Oct 21.
2
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic.大流行 6 个月后患风湿性疾病患者的 2019 年冠状病毒病结局。
Ann Rheum Dis. 2021 May;80(5):660-666. doi: 10.1136/annrheumdis-2020-219279. Epub 2020 Nov 30.
3
External COVID-19 Deep Learning Model Validation on ACR AI-LAB: It's a Brave New World.ACR人工智能实验室对外部新冠病毒深度学习模型的验证:这是一个全新的世界。
J Am Coll Radiol. 2022 Jul;19(7):891-900. doi: 10.1016/j.jacr.2022.03.013. Epub 2022 Apr 8.
4
Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study.因COVID-19住院的系统性风湿性疾病患者的实验室检查趋势、炎症反应过度及临床结局:一项回顾性比较队列研究
Lancet Rheumatol. 2021 Sep;3(9):e638-e647. doi: 10.1016/S2665-9913(21)00140-5. Epub 2021 May 28.
5
Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study.接受抗CD20单克隆抗体治疗的免疫介导疾病患者的2019冠状病毒病结局:一项比较队列研究
ACR Open Rheumatol. 2022 Mar;4(3):238-246. doi: 10.1002/acr2.11386. Epub 2021 Dec 10.
6
Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.与普通人群相比,风湿性疾病患者感染新型冠状病毒肺炎的风险及临床结局:一项系统评价和荟萃分析。
Rheumatol Int. 2021 May;41(5):851-861. doi: 10.1007/s00296-021-04803-9. Epub 2021 Mar 9.
7
Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population.COVID-19 患者的临床病程和结局:一项具有多样化人群的病例队列研究。
Clin Rheumatol. 2021 Jul;40(7):2633-2642. doi: 10.1007/s10067-021-05578-x. Epub 2021 Jan 9.
8
Automated Assessment and Tracking of COVID-19 Pulmonary Disease Severity on Chest Radiographs using Convolutional Siamese Neural Networks.使用卷积暹罗神经网络对胸部X光片上的COVID-19肺部疾病严重程度进行自动评估和跟踪。
Radiol Artif Intell. 2020 Jul 22;2(4):e200079. doi: 10.1148/ryai.2020200079. eCollection 2020 Jul.
9
Multi-population generalizability of a deep learning-based chest radiograph severity score for COVID-19.基于深度学习的 COVID-19 胸片严重程度评分在多人群中的泛化能力。
Medicine (Baltimore). 2022 Jul 22;101(29):e29587. doi: 10.1097/MD.0000000000029587.
10
Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry.种族和民族与风湿性疾病 COVID-19 结局的关联:来自 COVID-19 全球风湿病联盟医师注册处的数据。
Arthritis Rheumatol. 2021 Mar;73(3):374-380. doi: 10.1002/art.41567. Epub 2021 Feb 2.

引用本文的文献

1
Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases: A case-control study.系统性自身免疫性风湿病患者再次感染 COVID-19 的风险因素和结果:一项病例对照研究。
Semin Arthritis Rheum. 2023 Dec;63:152286. doi: 10.1016/j.semarthrit.2023.152286. Epub 2023 Oct 29.
2
A Hybrid Decision Tree and Deep Learning Approach Combining Medical Imaging and Electronic Medical Records to Predict Intubation Among Hospitalized Patients With COVID-19: Algorithm Development and Validation.一种结合医学影像和电子病历的混合决策树与深度学习方法,用于预测COVID-19住院患者的插管情况:算法开发与验证
JMIR Form Res. 2023 Oct 26;7:e46905. doi: 10.2196/46905.

利用深度学习衍生的胸部 X 光评分评估风湿性疾病与普通人群 COVID-19 肺部损伤的严重程度。

Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores.

机构信息

Massachusetts General Hospital and Harvard Medical School, Boston.

Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

Arthritis Care Res (Hoboken). 2023 Mar;75(3):657-666. doi: 10.1002/acr.24883. Epub 2022 Oct 21.

DOI:10.1002/acr.24883
PMID:35313091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9081965/
Abstract

OBJECTIVE

COVID-19 patients with rheumatic disease have a higher risk of mechanical ventilation than the general population. The present study was undertaken to assess lung involvement using a validated deep learning algorithm that extracts a quantitative measure of radiographic lung disease severity.

METHODS

We performed a comparative cohort study of rheumatic disease patients with COVID-19 and ≥1 chest radiograph within ±2 weeks of COVID-19 diagnosis and matched comparators. We used unadjusted and adjusted (for age, Charlson comorbidity index, and interstitial lung disease) quantile regression to compare the maximum pulmonary x-ray severity (PXS) score at the 10th to 90th percentiles between groups. We evaluated the association of severe PXS score (>9) with mechanical ventilation and death using Cox regression.

RESULTS

We identified 70 patients with rheumatic disease and 463 general population comparators. Maximum PXS scores were similar in the rheumatic disease patients and comparators at the 10th to 60th percentiles but significantly higher among rheumatic disease patients at the 70th to 90th percentiles (90th percentile score of 10.2 versus 9.2; adjusted P = 0.03). Rheumatic disease patients were more likely to have a PXS score of >9 (20% versus 11%; P = 0.02), indicating severe pulmonary disease. Rheumatic disease patients with PXS scores >9 versus ≤9 had higher risk of mechanical ventilation (hazard ratio [HR] 24.1 [95% confidence interval (95% CI) 6.7, 86.9]) and death (HR 8.2 [95% CI 0.7, 90.4]).

CONCLUSION

Rheumatic disease patients with COVID-19 had more severe radiographic lung involvement than comparators. Higher PXS scores were associated with mechanical ventilation and will be important for future studies leveraging big data to assess COVID-19 outcomes in rheumatic disease patients.

摘要

目的

患有风湿性疾病的 COVID-19 患者发生机械通气的风险高于普通人群。本研究旨在使用经过验证的深度学习算法评估肺部受累情况,该算法可提取放射学肺疾病严重程度的定量指标。

方法

我们对 COVID-19 诊断后±2 周内有≥1 张胸部 X 线片的风湿性疾病 COVID-19 患者和匹配的对照组进行了比较队列研究。我们使用未经调整和调整(年龄、Charlson 合并症指数和间质性肺病)分位数回归来比较两组第 10 至 90 百分位数的最大 X 射线肺严重程度(PXS)评分。我们使用 Cox 回归评估严重 PXS 评分(>9)与机械通气和死亡的相关性。

结果

我们确定了 70 例风湿性疾病患者和 463 例普通人群对照组。在第 10 至 60 百分位数,风湿性疾病患者和对照组的最大 PXS 评分相似,但在第 70 至 90 百分位数,风湿性疾病患者的评分明显更高(90 百分位数评分 10.2 比 9.2;调整后 P=0.03)。风湿性疾病患者更有可能出现 PXS 评分>9(20%比 11%;P=0.02),表明患有严重肺部疾病。PXS 评分>9 的风湿性疾病患者与 PXS 评分≤9 的患者相比,机械通气的风险更高(风险比 [HR] 24.1[95%置信区间 95%CI(95%CI)6.7,86.9])和死亡(HR 8.2[95%CI 0.7,90.4])。

结论

患有 COVID-19 的风湿性疾病患者的放射学肺部受累程度比对照组更严重。较高的 PXS 评分与机械通气相关,对于利用大数据评估风湿性疾病患者 COVID-19 结局的未来研究将很重要。